Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Fibroid Tumors (Uterine) 2017 NCI 5R01CA193583-02 Estrogen Signaling in a Mouse Model for Lymphangioleiomyomatosis HAMMES, STEPHEN UNIVERSITY OF ROCHESTER NY $351,608
Fibroid Tumors (Uterine) 2017 NCCIH 5R01AT008824-02 Botanical derived progestins and their impact on women's health BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $359,775
Fibroid Tumors (Uterine) 2017 NICHD 1R01HD087417-01A1 Molecular basis of MED12 in the pathogenesis of uterine fibroids BOYER, THOMAS UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $318,500
Fibroid Tumors (Uterine) 2017 NICHD 5R21HD085530-02 Dietary Supplementation with Flax as a Therapeutic Approach for Leiomyomas NOWAK, ROMANA UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $198,250
Fibroid Tumors (Uterine) 2017 NICHD 5R01HD076450-05 The role of REST in the pathogenesis of uterine fibroids CHENNATHUKUZHI, VARGHEESE UNIVERSITY OF KANSAS MEDICAL CENTER KS $335,250
Fibroid Tumors (Uterine) 2017 NICHD 5R01HD072489-05 Uterine Leiomyoma Development in Mouse Models TEIXEIRA, JOSE MICHIGAN STATE UNIVERSITY MI $353,412
Fibroid Tumors (Uterine) 2017 NICHD 1R21HD091337-01 Prospective Randomized Trial of Tranexamic Acid versus Levonorgestrel Intrauterine System for the Treatment of Heavy Menstrual Bleeding in Women with Uterine Fibroids LAUGHLIN-TOMMASO, SHANNON MAYO CLINIC ROCHESTER MN $164,794
Fibroid Tumors (Uterine) 2017 NIEHS 5R01ES024749-03 Endocrine disrupting chemicals and risk of uterine fibroids: a prospective study WISE, LAUREN BOSTON UNIVERSITY MEDICAL CAMPUS MA $643,310
Fibroid Tumors (Uterine) 2017 NICHD 1R01HD088629-01A1 Med12 mechanisms of uterine leiomyoma formation RAJKOVIC, ALEKSANDAR MAGEE-WOMEN'S RES INST AND FOUNDATION PA $339,823
Fibroid Tumors (Uterine) 2017 NICHD 5F32HD085685-03 The role of T2 and blood flow properties in MRgFUS treatments of uterine fibroids DILLON, CHRISTOPHER UNIVERSITY OF UTAH UT $59,166
Fibroid Tumors (Uterine) 2017 NICHD 1R21HD088868-01A1 Role of miR29c and miR200c in leiomyoma pathogenesis KHORRAM, OMID LA BIOMED RES INST/ HARBOR UCLA MED CTR CA $217,500
Fibroid Tumors (Uterine) 2017 NICHD 1F30HD089585-01A1 Early environmental and hormonal exposure influences on human myometrial cell population PRUSINSKI, LAUREN AUGUSTA UNIVERSITY GA $39,169
Fibroid Tumors (Uterine) 2017 NICHD 5P01HD057877-08 7969 Administrative Core BULUN, SERDAR NORTHWESTERN UNIVERSITY AT CHICAGO IL $133,954
Fibroid Tumors (Uterine) 2017 NICHD 5P01HD057877-08 7970 Paracrine Signaling for Functions of Leiomyoma Progenitor Stem Cells BULUN, SERDAR NORTHWESTERN UNIVERSITY AT CHICAGO IL $380,750
Fibroid Tumors (Uterine) 2017 NICHD 5P01HD057877-08 7974 Roles of Nuclear Receptors in Uterine Leiomyoma Proliferation and Fibrosis CHAKRAVARTI, DEBABRATA NORTHWESTERN UNIVERSITY AT CHICAGO IL $363,504
Fibroid Tumors (Uterine) 2017 NICHD 5P01HD057877-08 7975 AKT Pathway and Cell Fate in Uterine Leiomyomas KIM, JI-YONG NORTHWESTERN UNIVERSITY AT CHICAGO IL $353,997
Fibroid Tumors (Uterine) 2017 NICHD 5P01HD057877-08 7976 Role of EFEMP1 in the Pathogenesis of Leiomyoma MARSH, ERICA NORTHWESTERN UNIVERSITY AT CHICAGO IL $8,307
Fibroid Tumors (Uterine) 2017 NICHD 5R01HD089552-02 Integrative Genomics, Epigenomics and Bioinformatics Analyses of Human Uterine Fibroids CHAKRAVARTI, DEBABRATA NORTHWESTERN UNIVERSITY AT CHICAGO IL $678,468
Fibroid Tumors (Uterine) 2017 NICHD 5R01HD074711-05 Understanding the genetic risk underlying racial disparities in uterine fibroids VELEZ EDWARDS, DIGNA VANDERBILT UNIVERSITY MEDICAL CENTER TN $541,485
Fibroid Tumors (Uterine) 2017 NIEHS 1R01ES028235-01 Environmental risk factors for uterine fibroids: a prospective ultrasound study WEGIENKA, GANESA HENRY FORD HEALTH SYSTEM MI $646,003
Fibroid Tumors (Uterine) 2017 NCI 1R03CA219326-01 A Novel Mouse Model for Uterine Leiomyoma WONG, KWONG KWOK UNIVERSITY OF TX MD ANDERSON CAN CTR TX $80,000
Fibroid Tumors (Uterine) 2017 NIMHD 1R01MD011680-01 Racial Differences in Treatment with Hysterectomy: a Multilevel Investigation ROBINSON, WHITNEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $602,883
Fibroid Tumors (Uterine) 2017 NIEHS 1R01ES028615-01 Gene X Environment Interactions in the Pathogenesis of Uterine Fibroids AL-HENDY, AYMAN AUGUSTA UNIVERSITY GA $503,553
Fibroid Tumors (Uterine) 2017 NICHD 3F32HD085685-02S1 The role of T2 and blood flow properties in MRgFUS treatments of uterine fibroids DILLON, CHRISTOPHER UNIVERSITY OF UTAH UT $632
Fibroid Tumors (Uterine) 2017 NICHD 1R01HD093671-01 Large-scale studies in eMERGE to discover the genetic determinants of uterine fibroids VELEZ EDWARDS, DIGNA VANDERBILT UNIVERSITY MEDICAL CENTER TN $681,210
Fibroid Tumors (Uterine) 2017 NICHD 275201300019I-4-27500001-1 CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE ARCHER, DAVID F EASTERN VIRGINIA MEDICAL SCHOOL VA $9,609
Fibroid Tumors (Uterine) 2017 NIEHS 1ZIAES021196-24 Pathobiology Of Uterine Leiomyomas (fibroids) DIXON, DARLENE NIH $1,736,139
Fibroid Tumors (Uterine) 2017 NIEHS 1ZIAES049013-23 Uterine Leiomyomas BAIRD, DONNA NIH $909,979
Fibroid Tumors (Uterine) 2017 NIEHS 1ZIAES101663-15 Fibroid Growth Study PEDDADA, SHYAMAL NIH $50,151
Fibroid Tumors (Uterine) 2017 NIEHS 1ZIAES103106-06 Statistical collaboration in environmental health research KISSLING, GRACE NIH $150,453
Fibroid Tumors (Uterine) 2017 NIDDK 1ZIADK075123-02 Endometrial Physiology NIEMAN, LYNNETTE NIH $20,110


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer